Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001649094-25-000004
Filing Date
2025-01-07
Accepted
2025-01-07 16:33:34
Documents
1
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1736285608.html 4  
1 FORM 4 wk-form4_1736285608.xml 4 10918
  Complete submission text file 0001649094-25-000004.txt   12473
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, SUITE 300 SAN CARLOS CA 94070
Business Address
Eydelman Mikhail (Reporting) CIK: 0001918033 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 25515272